Clinical Trials Logo

Clinical Trial Summary

This is a phase II, randomized study of 120 adults age 18 or above who will prescribed 20mg daily Fluoxetine for 90 days following acute, ischemic stroke.

Clinical Trial Description

This is a prospective, phase II study of fluoxetine for motor recovery post-stroke in adults with new-onset ischemic stroke in urban Tanzania. Participants will be enrolled at the Muhimbili National Hospital (MNH) in Dar Es Salaam after confirmation of exclusion and inclusion criteria, including a head CT. Participants will be enrolled within 14 days of acute, ischemic stroke. The study will utilize a novel method for monitoring patient medication adherence: electronic pill bottles that can record opening and closing of the bottle's cap. The primary goals of this study are to assess the safety and tolerability of fluoxetine post-stroke to evaluate the feasibility of conducting a larger, phase III study in the future.

Vital status will be monitored throughout the study's enrollment period. After discharge from the hospital, participants will be seen at 30-, 60-, and 90-days post-enrollment for an in-person study visit. At each time point, investigators will draw 10-15 mL of blood; download medication adherence data from participants' electronic pill bottles; inquire about adverse events and evaluate patient disability through the modified Rankin Scale; and administer the Morisky Medication Adherence questionnaire. If participants stop taking their daily pill, stroke specific reasons for non-adherence will be inquired including dysphagia, self-administration, and other concerns.

Primary assessments will be for safety and tolerability, as well as measurement of the Fugl-Meyer Motor Scale. Medication use data will also be collected through the Morisky Medication Adherence Scale and from the electronic pill bottle, which will be returned to study investigators. As secondary assessments, the PHQ-9, and the Asberg Depressive Symptom Questionnaire will be administered. All 90-day assessments will be administered by senior site investigators, who will take a final 10-15mL blood draw to test for serum sodium and liver enzymes, possible adverse events related to long-term fluoxetine use, evaluate participant mRS, and inquire about tolerability issues. Completion of the 90-day visit and associated assessments is considered the study endpoint. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03728153
Study type Interventional
Source Massachusetts General Hospital
Contact Farrah J Mateen, MD, PhD
Phone 6177264540
Status Not yet recruiting
Phase Phase 2
Start date March 1, 2019
Completion date October 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT03477188 - The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke. N/A
Recruiting NCT02677415 - Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Completed NCT01210729 - Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke Phase 2
Recruiting NCT00785343 - Study of Robot-assisted Arm Therapy for Acute Stroke Patients Phase 1
Recruiting NCT02369770 - Sensory-Motor Rehabilitation Post Stroke N/A
Not yet recruiting NCT03359434 - Blood Pressure Measurement Methods and Prediction of Intracranial Hemorrhage After Thrombectomy in Stroke N/A
Completed NCT02720276 - Sms Guided Training After Acute Stroke N/A
Completed NCT03036020 - The Norwegian Acute Stroke Prehospital Project N/A
Completed NCT01501773 - Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke Phase 2
Terminated NCT00331890 - ICTUS Study: International Citicoline Trial on Acute Stroke Phase 3
Not yet recruiting NCT03144960 - Mechanical Thrombectomy Of Acute Occlusion In Ischemic Stroke N/A
Recruiting NCT02902367 - Sms-guided Training After Acute Stroke or Transient Ischemic Attack - a Randomized Controlled Trial N/A
Withdrawn NCT02098083 - Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes N/A
Terminated NCT01692379 - Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours Phase 3
Not yet recruiting NCT01442766 - Donepezil Trial for Motor Recovery in Acute Stroke Phase 1/Phase 2
Withdrawn NCT02907736 - Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
Recruiting NCT03297827 - Cytokine Registry Database of Stroke Patients
Not yet recruiting NCT03720522 - The Bern Heart and Brain Interaction Study - Interaction Between Brain and Heart in Acute Ischemic Stroke